Helix BioMedix partners with Sk:n to launch anti-blemish products

BOTHELL, Wash. — Helix BioMedix, a developer of bioactive peptides, has announced that three new anti-blemish products developed by the company have been launched by Sk:n, a U.K. skin health clinic.



The products debuted at the 37 Sk:n clinics and larger Boots Chemist shops across the United Kingdom starting July 4, and are part of an extensive line under the Sk:n brand. The collection is split into cleansing and exfoliating, anti-aging, anti-blemish, corrective and protect treatment areas, and will form part of Boots' dermatological offering, which currently features such brands as Vichy and Avène.



"We are pleased to partner with the U.K.'s premier dermatology group to bring innovative, problem-solving skin care products to market. We feel that Sk:n is uniquely suited to bridge the best of the dermatology and consumer skin care continuum, and we are delighted our patented technology and targeted formulations bring benefit to acne sufferers," stated R. Stephen Beatty, president and CEO of Helix BioMedix.